Cholinergic regulation of morphine release from human white blood cells: Evidence for a novel nicotinic receptor via pharmacological and microarray analysis

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 2, 2007, Pages 229-237

  Zhu, W ^a   Mantione, K J ^a   Kream, R M ^b   Cadet, P ^a   Stefano, George B ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Cholinergic receptors; Microarray; Morphine; Nicotine; Nicotinic receptors; White blood cells

Indexed keywords

ALPHA BUNGAROTOXIN; ATROPINE; CHLORISONDAMINE; CHLORISONDAMINE DIIODIDE; CHOLINERGIC RECEPTOR; DIHYDRO BETA ERYTHROIODINE HYDROBROMIDE; EPIBATIDINE; HEXAMETHONIUM CHLORIDE; IODINE 125; MORPHINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR BLOCKING AGENT; RNA; UNCLASSIFIED DRUG;

ARTICLE; AUTONOMIC GANGLION; BLOOD ANALYSIS; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOTOPE LABELING; LEUKOCYTE; MICROARRAY ANALYSIS; MONONUCLEAR CELL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; RECEPTOR BLOCKING; RNA ANALYSIS; RNA ISOLATION; STATISTICAL SIGNIFICANCE; STIMULATION;

EID: 34547122863     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000203     Document Type: Article

References (36)

1. Zhu W., P. Cadet, G. Baggerman, K.J. Mantione and G.B. Stefano. 2005. Human white blood cells synthesize morphine: CYP2D6 modulation. J. Immunol. 175:7357.
2. Zhu W., K.J. Mantione, L. Shen, P. Cadet, T. Esch, Y. Goumon, E. Bianchi, D. Sonetti and G.B. Stefano. 2005. Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: CYP2D6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med. Sci. Monit. 11:397.
3. Zhu W., K.J. Mantione, F.M. Casares, P. Cadet, J.W. Kim, T.V. Bilfinger, R.M. Kream, S. Khalil, S. Singh and G.B. Stefano. 2006. Alcohol-, nicotine, and cocaine-evoked release of morphine from invertebrate ganglia: model system for screening drugs of abuse. Med. Sci. Monit. 12:155.
4. Zhu W., K.J. Mantione, F.M. Casares, M.H. Sheehan, R.M. Kream and G.B. Stefano. 2006. Cholinergic regulation of endogenous morphine release from lobster nerve cord. Med. Sci. Monit. 12:295.
5. Zhu W., K. Mantione, R.M. Kream and G.B. Stefano. 2006. alcohol-, nicotine-, and cocaine-evoked release of morphine from human white blood cells: substances of abuse actions converge on endogenous morphine release. Med. Sci. Monit. 12:350.
6. Zhu W., G. Baggerman, Y. Goumon, F. Casares, B. Brownawell and G.B. Stefano. 2001. Presence of morphine and morphine-6-glucuronide in the marine mollusk Mytilus edulis ganglia determined by GC/MS and Q-TOF-MS. Starvation increases opiate alkaloid levels. Brain Res. Mol. Brain Res. 88:155.
7. Zhu W., Y. Ma, P. Cadet, D. Yu, T.V. Bilfinger, E. Bianchi and G.B. Stefano. 2003. Presence of reticuline in rat brain: A pathway for morphine biosynthesis. Mol. Brain Res. 117:83.
8. Zhu W., G. Baggerman, Y. Goumon, M.H. Zenk and G.B. Stefano. 2001. Identification of morphine and morphine-6-glucuronide in the adrenal medullary chromaffin PC-12 cell line by nano electrospray ionization double quadrupole orthogonal acceleration time of flight mass spectrometry. Eur. J. Mass Spect. 7:25.
9. Zhu W., Y. Ma and G.B. Stefano. 2002. Presence of isoquinoline alkaloids in molluscan ganglia. Neuroendocrinal. Lett. 23:329.
10. Zhu W. and G.B. Stefano. 2004. Reticuline exposure to invertebrate ganglia increases endogenous morphine levels. Neuroendocrinol. Lett. 25:323.
11. Hamano R., H.K. Takahashi, H. Iwagaki, T. Yoshino, M. Nishibori and N. Tanaka. 2006. Stimulation of alpha7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes. Shock 26:358.
12. Esch T. and G.B. Stefano. 2004. The neurobiology of pleasure, reward processes, addiction and their health implications. Neuroendocrinol. Lett. 25:235.
13. Nakajima M. and T. Yokoi. 2005. Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation. Drug Metab. Pharmacokinet. 20:227.
14. Yoshimura R., L. Xu, B. Sun and A.W. Tank. 2004. Nicotinic and muscarinic acetylcholine receptors are essential for the long-term response of tyrosine hydroxylase gene expression to chronic nicotine treatment in rat adrenal medulla. Brain Res. Mol. Brain Res. 126:188.
15. Goumon Y., A. Muller, E. Glattard, C. Marban, C. Gasnier, J.M. Strub, S. Chasserot-Golaz, O. Rohr, G.B. Stefano, I.D. Welters, A. Van Dorsselaer, F. Schoentgen, D. Aunis and M.H. Metz-Boutigue. 2006. Identification of morphine-6-glucuronide in chromaffin cell secretory granules. J. Biol. Chem. 281:8082.
16. Damaj M.I., M. Fei-Yin, M. Dukat, W. Glassco, R.A. Glennon and B.R. Martin. 1998. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J. Pharmacol. Exp. Ther. 284:1058.
17. Marks M.J., P. Whiteaker and A.C. Collins. 2006. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine. Mol. Pharmacol. 70:947.
18. Parish C.L., J. Nunan, D.I. Finkelstein, F.N. McNamara, J.Y. Wong, J.L. Waddington, R.M. Brown, A.J. Lawrence, M.K. Horne and J. Drago. 2005. Mice lacking the alpha4 nicotinic receptor subunit fail to modulate dopaminergic neuronal arbors and possess impaired dopamine transporter function. Mol. Pharmacol. 68:1376.
19. Nimit Y., I. Schulze, J.L. Cashaw, S. Ruchirawat and V.E. Davis. 1983. Interaction of catecholamine-derived alkaloids with central neurotransmitter receptors. J. Neurosci. Res. 10:175.
20. Seevers M.H., V.E. Davis and M.J. Walsh. 1970. Morphine and ethanol physical dependence: a critique of a hypothesis. Science 170:1113.
21. Davis V.E. and M.J. Walsh. 1970. Alcohol, amines and alkaloids: a possible biochemical basis for alcohol addiction. Science 167:1005.
22. Kream R.M. and G.B. Stefano. 2006. De novo biosynthesis of morphine in animal cells: An evidence-based model. Med. Sci. Monit. 12:207.
23. Cashaw J.L., C.A. Geraghty, B.R. McLaughlin and V.E. Davis. 1987. Effect of acute ethanol administration on brain levels of tetrahydropapaveroline in L-dopa-treated rats. J. Neurosci. Res. 18:497.
24. Haber H., I. Roske, M. Rottmann, M. Georgi and M.F. Melzig. 1997. Alcohol induces formation of morphine precursors in the striatum of rats. Life Sciences 60:79.
25. Ingvar M., P.H. Ghatan, A. Wirsen-Meurling, J. Risberg, G. Von Heijne, S. Stone-Elander and D.H. Ingvar. 1998. Alcohol activates the cerebral reward system in man. J. Stud. Alcohol 59:258.
26. Rossetti Z.L., Y. Hmaidan and G.L. Gessa. 1992. Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 221:227.
27. Pierce R.C. and V. Kumaresan. 2006. The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neurosci. Biobehav. Rev. 30:215.
28. Larsson A. and J.A. Engel. 2004. Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci. Biobehav. Rev. 27:713.
29. Dohrman D.P. and C.K. Reiter. 2003. Chronic ethanol reduces nicotine-induced dopamine release in PC12 cells. Alcohol Clin. Exp. Res. 27:1846
30. Larsson A., L. Svensson, B. Soderpalm and J.A. Engel. 2002. Role of different nicotinic acetylcholine receptors in mediating behavioral and neurochemical effects of ethanol in mice. Alcohol 28:157.
31. Tizabi Y., R.L. Copeland, Jr, V.A. Louis and R.E. Taylor. 2002. Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens. Alcohol Clin. Exp. Res. 26:394.
32. Soderpalm B., M. Ericson, P. Olausson, O. Blomqvist and J.A. Engel. 2000. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav. Brain Res. 113:85.
33. Cormier A., Y. Paas, R. Zini, J.P. Tillement, G. Lagrue, J.P. Changeux and R. Grailhe. 2004. Long-term exposure to nicotine modulates the level and activity of acetylcholine receptors in white blood cells of smokers and model mice. Mol. Pharmacol. 66:1712.
34. Stefano G.B., B. Scharrer, E.M. Smith, T.K. Hughes, H.I. Magazine, T.V. Bilfinger, A. Hartman, G.L. Fricchione, Y. Liu and M.H. Makman. 1996. Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol. 16:109.
35. Bainton R.J., L.T. Tsai, C.M. Singh, M.S. Moore, W.S. Neckameyer and U. Heberlein. 2000. Dopamine modulates acute responses to cocaine, nicotine and ethanol in Drosophila. Curr. Biol. 10:187.
36. Nestler E.J. 2005. Is there a common molecular pathway for addiction? Nat. Neurosci. 8:1445.